SCHEMBL14860945

SCHEMBL14860945

Nc1nc2cccc(-c3ccccc3)c2s1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASH1L Q9NR48 1/20 0.62
PIK3CA P42336 3/20 0.47
PI4KA P42356 2/20 0.47
PI4KB Q9UBF8 2/20 0.47
ALDH1A1 P00352 7/20 0.44
MAPT P10636 4/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 2/20 0.44
LIMK1 P53667 2/20 0.44
HSD17B10 Q99714 1/20 0.41
KDM4E B2RXH2 2/20 0.40
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40
CYP2C9 P11712 1/20 0.40
PIK3CD O00329 2/20 0.40
PIK3CG P48736 2/20 0.40
PIK3CB P42338 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
IKBKB O14920 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31621268 1.00 ASH1L (0.62) ASH1LPIK3CAPI4KAPI4KBALDH1A1
SCHEMBL2624081 0.83 ALDH1A1 (0.50) ASH1LALDH1A1MAPTHSD17B10KDM4E
SCHEMBL189244 0.82 ASH1L (0.59) ASH1LPIK3CAPI4KAPI4KBALDH1A1
SCHEMBL29013240 0.79 ASH1L (0.49) ASH1LALDH1A1MAPTLIMK1HSD17B10
SCHEMBL30312029 0.79 ASH1L (0.49) ASH1LALDH1A1MAPTLIMK1HSD17B10
SCHEMBL30128071 0.79 PIK3CA (0.45) ASH1LPIK3CAPI4KAPI4KBALDH1A1
SCHEMBL22027627 0.79 PIK3CA (0.45) ASH1LPIK3CAPI4KAPI4KBALDH1A1
SCHEMBL30311933 0.79 ASH1L (0.59) ASH1LALDH1A1MAPTCYP1A2CYP2C19
SCHEMBL30311887 0.79 ASH1L (0.59) ASH1LKDM4EIKBKBADORA2AADORA1
SCHEMBL29013266 0.79 ASH1L (0.59) ASH1LKDM4EIKBKBADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115850263-A 2, 7-disubstituted benzothiazole compound and application thereof 浙江工业大学 2023-03-28 CN disclosed
EP-2766359-A2 HETEROCYCLIC COMPOUNDS AND USE THEREOF AS MODULATORS OF TYPE III RECEPTOR TYROSINE KINASES Ambit Biosciences Corporation (US) 2014-08-20 EP disclosed
WO-2013056070-A2 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2013-04-18 WO disclosed